Skip to content

Up2info.com

News / Analytics / Reviews

  • Stock Market Analysis
  • Corporate News
  • Financial News

Tag: JNJ

J&J hits main goal in early-stage trial for drug delivery system

Johnson & Johnson (JNJ) announced on Friday the achievement of a primary safety endpoint in a Phase 1 trial for a drug...

wpadmin
March 13, 2026

J&J wins FDA nod for Tecnis PureSee intraocular lens

Johnson & Johnson (JNJ) announced on Thursday that the U.S. Food and Drug Administration (FDA) approved its Tecnis...

wpadmin
March 12, 2026

J&J subsidiaries ink $65M deal to resolve Tracleer antitrust case

Johnson & Johnson (JNJ) subsidiaries Actelion Pharmaceuticals and ‌Janssen Research & Development have agreed to...

wpadmin
March 6, 2026

Pharma giants pressed by Senate Democrats over Trump pricing deals

Six Democratic senators, including Senate Finance Committee Ranking Member Ron Wyden (D-Ore.), have sent letters to more...

wpadmin
March 6, 2026

J&J wins FDA nod for multiple myeloma therapy

The U.S. Food and Drug Administration on Thursday approved Johnson & Johnson's (JNJ) antibody therapy Tecvayli...

wpadmin
March 5, 2026

Kenvue effort to dismiss Tylenol case rejected by Texas judge

A bid by Kenvue (KVUE) to dismiss a lawsuit brought against it by Texas Attorney General Ken Paxton accusing the company of...

wpadmin
February 26, 2026

J&J seeks additional indication for Imaavy for rare type of anemia

Johnson & Johnson (JNJ) has submitted a supplemental New Drug Application to the US FDA seeking approval of Imaavy...

wpadmin
February 24, 2026

Bayer sues Johnson & Johnson over prostate cancer drug claims

New Jersey-based Johnson & Johnson (JNJ) defended its testing and marketing. "Litigation does not change data," a...

wpadmin
February 24, 2026

Dividend Roundup: Halliburton, AbbVie, Johnson & Johnson, Delta Air Lines, and more

This week's dividend activity included increased payouts from Sherwin-Williams (SHW) and Analog Devices (ADI) as well as...

wpadmin
February 20, 2026

Johnson & Johnson considering sale of orthopedics business – report

Johnson & Johnson (JNJ) is exploring a sale of its orthopedics business, DePuy Synthes, in a deal that could have a...

wpadmin
February 19, 2026

Posts navigation

Older posts

Powered By WordPress | Newsmagify